These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20141358)

  • 1. Does acute loss of vision in autosomal dominant optic atrophy occur early in childhood?
    Kearns LS; Forrest M; Cohn AC; Churchill AJ; Mackey DA
    Ophthalmic Genet; 2010 Mar; 31(1):44-6. PubMed ID: 20141358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history of OPA1-related autosomal dominant optic atrophy.
    Cohn AC; Toomes C; Hewitt AW; Kearns LS; Inglehearn CF; Craig JE; Mackey DA
    Br J Ophthalmol; 2008 Oct; 92(10):1333-6. PubMed ID: 18653586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations.
    Ferré M; Bonneau D; Milea D; Chevrollier A; Verny C; Dollfus H; Ayuso C; Defoort S; Vignal C; Zanlonghi X; Charlin JF; Kaplan J; Odent S; Hamel CP; Procaccio V; Reynier P; Amati-Bonneau P
    Hum Mutat; 2009 Jul; 30(7):E692-705. PubMed ID: 19319978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations.
    Cohn AC; Toomes C; Potter C; Towns KV; Hewitt AW; Inglehearn CF; Craig JE; Mackey DA
    Am J Ophthalmol; 2007 Apr; 143(4):656-62. PubMed ID: 17306754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations.
    Ito Y; Nakamura M; Yamakoshi T; Lin J; Yatsuya H; Terasaki H
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4079-86. PubMed ID: 17724190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of oscillatory potentials and photopic negative response in patients with autosomal dominant optic atrophy with OPA1 mutations.
    Miyata K; Nakamura M; Kondo M; Lin J; Ueno S; Miyake Y; Terasaki H
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):820-4. PubMed ID: 17251483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial DNA content is decreased in autosomal dominant optic atrophy.
    Kim JY; Hwang JM; Ko HS; Seong MW; Park BJ; Park SS
    Neurology; 2005 Mar; 64(6):966-72. PubMed ID: 15781809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy.
    Thiselton DL; Alexander C; Taanman JW; Brooks S; Rosenberg T; Eiberg H; Andreasson S; Van Regemorter N; Munier FL; Moore AT; Bhattacharya SS; Votruba M
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1715-24. PubMed ID: 12036970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal dominant hereditary optic neuropathy (ADOA): a review of the genetics and clinical manifestations of ADOA and ADOA+.
    Skidd PM; Lessell S; Cestari DM
    Semin Ophthalmol; 2013; 28(5-6):422-6. PubMed ID: 24138050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic basis of hereditary optic atrophies].
    Wawrocka A; Krawczyński MR
    Klin Oczna; 2007; 109(10-12):470-4. PubMed ID: 18488399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophthalmoplegia: a syndrome caused by a missense mutation in OPA1.
    Payne M; Yang Z; Katz BJ; Warner JE; Weight CJ; Zhao Y; Pearson ED; Treft RL; Hillman T; Kennedy RJ; Meire FM; Zhang K
    Am J Ophthalmol; 2004 Nov; 138(5):749-55. PubMed ID: 15531309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary optic neuropathies share a common mitochondrial coupling defect.
    Chevrollier A; Guillet V; Loiseau D; Gueguen N; de Crescenzo MA; Verny C; Ferre M; Dollfus H; Odent S; Milea D; Goizet C; Amati-Bonneau P; Procaccio V; Bonneau D; Reynier P
    Ann Neurol; 2008 Jun; 63(6):794-8. PubMed ID: 18496845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant optic atrophy: correlation between clinical and molecular genetic studies.
    Puomila A; Huoponen K; Mäntyjärvi M; Hämäläinen P; Paananen R; Sankila EM; Savontaus ML; Somer M; Nikoskelainen E
    Acta Ophthalmol Scand; 2005 Jun; 83(3):337-46. PubMed ID: 15948788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. eOPA1: an online database for OPA1 mutations.
    Ferré M; Amati-Bonneau P; Tourmen Y; Malthièry Y; Reynier P
    Hum Mutat; 2005 May; 25(5):423-8. PubMed ID: 15832306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The G401D mutation of OPA1 causes autosomal dominant optic atrophy and hearing loss in a Chinese family.
    Ke T; Nie SW; Yang QB; Liu JP; Zhou LN; Ren X; Liu JY; Wang Q; Liu MG
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Oct; 23(5):481-5. PubMed ID: 17029191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural model of the OPA1 GTPase domain may explain the molecular consequences of a novel mutation in a family with autosomal dominant optic atrophy.
    Dadgar S; Hagens O; Dadgar SR; Haghighi EN; Schimpf S; Wissinger B; Garshasbi M
    Exp Eye Res; 2006 Sep; 83(3):702-6. PubMed ID: 16698014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal vessel diameters decrease with macular ganglion cell layer thickness in autosomal dominant optic atrophy and in healthy subjects.
    Rönnbäck C; Grønskov K; Larsen M
    Acta Ophthalmol; 2014 Nov; 92(7):670-4. PubMed ID: 24612963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fourteen novel OPA1 mutations in autosomal dominant optic atrophy including two de novo mutations in sporadic optic atrophy.
    Baris O; Delettre C; Amati-Bonneau P; Surget MO; Charlin JF; Catier A; Derieux L; Guyomard JL; Dollfus H; Jonveaux P; Ayuso C; Maumenee I; Lorenz B; Mohammed S; Tourmen Y; Bonneau D; Malthièry Y; Hamel C; Reynier P
    Hum Mutat; 2003 Jun; 21(6):656. PubMed ID: 14961560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A frameshift mutation in exon 28 of the OPA1 gene explains the high prevalence of dominant optic atrophy in the Danish population: evidence for a founder effect.
    Thiselton DL; Alexander C; Morris A; Brooks S; Rosenberg T; Eiberg H; Kjer B; Kjer P; Bhattacharya SS; Votruba M
    Hum Genet; 2001 Nov; 109(5):498-502. PubMed ID: 11735024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OPA1-associated disorders: phenotypes and pathophysiology.
    Amati-Bonneau P; Milea D; Bonneau D; Chevrollier A; Ferré M; Guillet V; Gueguen N; Loiseau D; de Crescenzo MA; Verny C; Procaccio V; Lenaers G; Reynier P
    Int J Biochem Cell Biol; 2009 Oct; 41(10):1855-65. PubMed ID: 19389487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.